Mr. Justin Hanka reports

MINDBIO ADVANCES LARGE-SCALE DEPLOYMENT OF VOICE INTOXICATION DETECTION THROUGH INTEGRATED EDGE AI HARDWARE-SOFTWARE PLATFORM

Mindbio Therapeutics Corp. has commenced development of a proprietary edge computing platform, including dedicated hardware, to enable large-scale deployment in the mining industry.

The company is working with an experienced engineering firm with expertise in hardware and sensor development to design and manufacture the company's integrated Edge AI solution for real-time, on-device voice analysis in remote and infrastructure-limited environments. Prototype development is nearing completion, with hardware manufacturing and field-ready deployment expected in Q2 2026.

The Mindbio hardware device will be sold direct and via distribution channels. Every device will also have a recurring revenue stream for use of the installed software -- the Voice AI intoxication detection models developed by Mindbio.

Mindbio is actively pursuing enterprise-level commercialization opportunities, with its first targeted deployment focused on the mining sector. The company has initiated operations in South America and deployed engineering personnel to support development of an industry-specific testing protocol. Mindbio is working with mining operators and health authorities in Chile to align its technology with existing regulatory frameworks, where government-mandated drug and alcohol testing is in place.

Upon completion, the Edge AI platform is expected to support scalable deployment across additional safety critical industries, including aviation and heavy industrial sectors, where zero-tolerance policies exist but current testing methods are invasive, episodic and costly.

Work force studies in Chile indicate alcohol consumption among mining workers exceeds 75 per cent, with more than 40 per cent classified as problem drinkers and approximately 9 per cent reporting drug use across a work force of more than 200,000 individuals (ACHS, 2012; SENDA, 2024). Internationally, 20 to 25 per cent of occupational accidents are estimated to be directly or indirectly linked to substance use (International Labour Organization, 1996; 2022; Gomez et al., 2002). These data underscore a significant global market opportunity for scalable, non-invasive intoxication detection technologies.

Justin Hanka, chief executive officer of Mindbio, commented:

"Mindbio is leveraging its first-mover position in AI-powered voice diagnostics to develop scalable workplace health and safety solutions addressing drug and alcohol impairment. We are encouraged by early industry engagement and look forward to initial deployment in Chile's mining sector, followed by broader expansion across South America and other global markets."

About Mindbio Therapeutics Corp.

Mindbio is a biotechnology company that is commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is now collecting data that will allow its prediction tool to work on other types of intoxication for use in consumer and enterprise environments.

We seek Safe Harbor.